La Crosse Method Practice Protocol

August 8, 2018

Does SLIT impact asthma? New review indicates yes.

By Taylor Pasell, Allergychoices

Big news for sublingual immunotherapy came in the form of a comparative effectiveness review recently. A group of allergy researchers compared 31 subcutaneous immunotherapy studies, 18 sublingual immunotherapy studies, and 5 combined studies “to assess the efficacy and safety of immunotherapy for treating allergic asthma.” The results showed […]

More »

, , ,

April 19, 2017

Allergic asthma: How sublingual immunotherapy treatment can impact asthma

By: Emily Martin, Allergychoices

According to the Center for Disease Control, more than 25 million Americans suffer from asthma and 56.3% of patients have asthma caused by allergy. How can you tell when asthma may be a problem, and how can treating your allergies with sublingual immunotherapy help?

Asthma is a chronic inflammatory disease, and […]

More »

, , ,

April 5, 2017

Can treating allergies alleviate migraine symptoms?

By: Emily Martin, Allergychoices

Migraines can make even your simplest daily tasks extremely difficult and painful, and more than three million Americans experience migraines each year. While over-the-counter medications can make your migraines more tolerable, treating your allergies may help to alleviate your migraine symptoms when an underlying allergy is a factor.

Symptoms of […]

More »

, , , ,

January 25, 2017

Epinephrine and education: Perspectives using the La Crosse Method

By Michael B. Kachel, RPh, Allergychoices Pharmacy

With the recent controversy over skyrocketing EpiPen prices, more patients and providers are scrutinizing when—or whether—the life-saving epinephrine device is needed for use with sublingual immunotherapy using the La Crosse Method Protocol.

In the experience of the La Crosse Method Protocol authors, the safety of […]

More »

, , ,